investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Generation of Highly Avid Anti-Tumor CTL for Optimal Adoptive Immunotherapy
Naoto Hirano
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Naoto Hirano
University Health Network
Toronto, Canada
Related projects
Lewis Kay
CRC Tier 1 - Develop new Nuclear Magnetic Resonance Spectroscopy based techniques for relating molecular motions to function
All cancers but non-melanoma skin cancer
Akil Hamza
Human complementation of yeast mutations to identify candidate cancer therapeutic targets
All cancers but non-melanoma skin cancer
Peter Stirling
Understanding and exploiting genome instability in cancer
All cancers but non-melanoma skin cancer
Deborah Morrison
Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction
All cancers but non-melanoma skin cancer
Gregg Morin
Recurrent Somatic DICER1 Mutations: Functional Implication and Role in Oncogenesis
All cancers but non-melanoma skin cancer
A. K. M. Nur-Ur Rahman
Defining the role of T cell metabolism in HIV-induced chronic immune activation and immune dysfunction.
All cancers but non-melanoma skin cancer
Stefan Taubert
CRC Tier 2 - Studying Mediator Components
All cancers but non-melanoma skin cancer
Shun-Cheng Li
Identification of protein-protein interactions and the resultant signaling networks (CANADA RESEARCH CHAIRHOLDER)
All cancers but non-melanoma skin cancer
Paul Randazzo
Regulation of ADP-Ribosylation Factor
All cancers but non-melanoma skin cancer
